Aligos Therapeutics, Inc. (ALGS)

NASDAQ: ALGS · Real-Time Price · USD

6.44

+0.41 (6.80%)

At close: May 8, 2026, 4:00 PM EDT

6.24

-0.20 (-3.11%)

After-hours: May 8, 2026, 7:59 PM EDT

Aligos Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	29.98	18.3	37	135.7	81.35	186.82
Short-Term Investments	24.93	59.54	19.94	-	44.48	3.92
Cash & Short-Term Investments	54.91	77.84	56.94	135.7	125.83	190.73
Cash Growth	-60.17%	36.71%	-58.04%	7.85%	-34.03%	-21.67%
Other Current Assets	4.72	5.02	5.2	5.38	7.72	13.69
Total Current Assets	59.63	82.86	62.14	141.08	133.55	204.42
Net Property, Plant & Equipment	4.17	4.96	7.33	9.82	12.51	14.97
Long-Term Investments	-	-	-	-	-	15.11
Other Long-Term Assets	0.76	0.72	0.63	0.63	0.63	0.87
Total Assets	64.56	88.53	70.09	151.53	146.69	235.37
Accounts Payable	7.64	3.98	2.57	2.52	4.74	3.02
Accrued Expenses	11.99	13.53	15.56	16.84	16.04	25.39
Current Portion of Leases	3.69	3.73	3.46	3.24	3.14	2.91
Unearned Revenue	-	-	0.15	1.31	9.21	7.64
Total Current Liabilities	23.32	21.23	21.74	23.91	33.13	38.96
Long-Term Leases	0.66	1.53	4.92	7.9	9.43	11.55
Other Long-Term Liabilities	8.79	12.23	72.41	27.64	0.23	0.13
Total Long-Term Liabilities	9.45	13.76	77.33	35.54	9.66	11.68
Total Liabilities	32.77	34.99	99.07	59.45	42.79	50.64
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-in Capital	696.58	695.27	588.58	578.33	502.61	487.35
Accumulated Other Comprehensive Income	0.44	0.47	0.45	0.55	0.4	0.45
Retained Earnings	-665.24	-642.2	-618.01	-486.8	-399.12	-303.07
Shareholders' Equity	31.79	53.55	-28.97	92.08	103.9	184.73
Total Liabilities & Equity	64.56	88.53	70.09	151.53	146.69	235.37
Total Debt	4.35	5.25	8.38	11.14	12.57	14.46
Net Cash (Debt)	50.56	72.59	48.56	124.57	113.25	176.28
Net Cash Growth	-30.36%	49.48%	-61.01%	9.99%	-35.75%	-23.52%
Net Cash Per Share	4.87	7.34	7.75	48.59	66.31	110.57
Book Value	31.79	53.55	-28.97	92.08	103.9	184.73
Book Value Per Share	3.06	5.42	-4.62	35.92	60.84	115.87
Tangible Book Value	31.79	53.55	-28.97	92.08	103.9	184.73
Tangible Book Value Per Share	3.06	5.42	-4.62	35.92	60.84	115.87

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q